Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2000
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2342218A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341612A1 Indazole derivatives with 5-ht2 receptor activity
03/09/2000CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341454A1 Method for administering insulinotropic peptides
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/08/2000EP0983765A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance
03/08/2000EP0983726A1 Amino acid-trehalose composition
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983270A1 PROCESS FOR PREPARING 6-$i(O)-MONOESTERS OF CASTANOSPERMINE
03/08/2000EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists
03/08/2000EP0983226A1 New nitromethyl ketones, process for preparing them and compositions containing them
03/08/2000EP0983091A1 Obesity protein formulations
03/08/2000EP0983084A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
03/08/2000EP0983066A1 Pharmaceutical composition comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
03/08/2000EP0982990A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use
03/08/2000EP0770082B1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246801A Arginine silicate inositol complex and use thereof
03/08/2000CN1246798A Use of gastrointestinal lipase inhibitors
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246368A Medicinal liquor for treating hyperlipemia and hyperviscosity blood
03/08/2000CN1246363A Medicine for treating diabets mellitus and its preparing process
03/08/2000CN1050128C 5-acrylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034275 Tertiary amines
03/07/2000US6034255 Inhibitors of cholesterol esterase
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034216 Low molecular weight peptidomimetic growth hormone secretagogues
03/07/2000US6034132 Method of reducing bodyweight and treating obesity
03/07/2000US6034123 Method for altering blood lipid levels
03/07/2000US6034115 Indolyl-substituted phenylacetic acid derivatives
03/07/2000US6034098 Inhibitors of microsomal triglyceride transfer protein and method
03/07/2000US6034059 Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrients
03/07/2000US6034054 Solution containing tris buffer, arginine, zinc and preservative
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033693 Calcium product and a raw material for the product and processes for their preparation
03/07/2000CA2195093C Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
03/07/2000CA2030401C Inhibition of the abstinence syndrome
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011030A2 Method for chromatographically purifying insulins
03/02/2000WO2000011029A2 Novel anti-diabetic peptides
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010962A1 Chromium l-threonate, process for preparation of the same and their use
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010586A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010545A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
03/02/2000WO1999064409A3 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000DE19838097A1 Verfahren zur chromatographischen Reinigung von Insulinen Method for the chromatographic purification of insulins
03/02/2000DE19816894C1 SREBP-2-defiziente Zellinien SREBP-2-deficient cell lines
03/02/2000CA2342503A1 Quinazoline derivatives
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339775A1 Vitamin d3 mimics
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/01/2000EP0982315A2 Preparation of sterol and stanol esters
03/01/2000EP0982305A1 Indane-1-ol derivatives, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2)
03/01/2000EP0981526A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0981523A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1$g(a) (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
03/01/2000EP0981515A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
03/01/2000EP0981514A1 3-epi vitamin d2 compounds and uses thereof
03/01/2000EP0981374A2 Sustained-release delayed gels
03/01/2000EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions
03/01/2000EP0981346A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
03/01/2000EP0981338A1 ORAL PREPARATION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF $i(HELICOBACTER SP.) INFECTION
03/01/2000EP0981282A1 Process for preparing a nutritional supplement
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246154A OB fusion protein compositions and methods
03/01/2000CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments
03/01/2000CN1246110A Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same
03/01/2000CN1245810A Preparation of sterol and dihydro-sterol ester
02/2000
02/29/2000US6031004 Metformin (2:1) fumarate and metformin (2:1) succinate; antidiabetic and hypoglycemic agents; improved handling, i.e. lower hygroscopicity, free-flowing, reduced compaction susceptibiity, corrosion resistance; improved taste
02/29/2000US6030993 2-hydroxypropionic acid derivative and its manufacturing method
02/29/2000US6030990 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
02/29/2000US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse;
02/29/2000US6030979 Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Quinolizinium derivatives and the salts thereof
02/29/2000US6030953 For preventing and treating anal leakage of oil in a patient
02/29/2000US6030837 Antisense inhibition of PEPCK-mitochondrial expression
1 ... 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 ... 1298